Is DNASE2 p.Pro71Ser (c.211C>T) pathogenic?

DNASE2 p.Pro71Ser (c.211C>T) is classified Benign/Likely benign in DNASE2 (ClinVar, Multiple submitters, 4 submitters; last evaluated 2026-01-11). AlphaMissense: likely benign (0.0592); Rare (popmax 0.54%, afr).

How common is DNASE2 p.Pro71Ser (c.211C>T) in the general population?

DNASE2 p.Pro71Ser (c.211C>T) is rare (popmax 0.54%, afr) (gnomAD).

What do computational predictors say about DNASE2 p.Pro71Ser (c.211C>T)?

AlphaMissense predicts likely benign (score 0.0592) — an in-silico prediction, not a clinical call.

DNASE2 p.Pro71Ser

c.211C>T · rs150023166 · VCV1167607

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 4 submitters

AlphaMissense

likely benign

0.0592 · ACMG-weighted

gnomAD v4.1

Rare

rare (popmax 0.54%, afr)

Missense predictors

0/3 damaging

AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense	0.0592	likely benign
REVEL	0.021	moderately benign-leaning
SaProt	LLR -0.59	tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 1.2	GERP -0.54, phastCons 1
Regional constraint	o/e 0.91	unconstrained · MANE · 5,382 bp · p 0.057 · regional, not allelic
Overall
CADD	13.28	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.54% African / African-American · 405/75,064 alleles

Filtering AF 0.496% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.479%

Overall 0.027% 435/1,613,806 alleles · rare

Ancestry group	Frequency	1 in
African / African-Americangrpmax	0.54%	185
Admixed American	0.0217%	4,617
Middle Eastern	0.0165%	6,052
Remaining individualsnot grpmax-eligible	0.016%	6,249
European (non-Finnish)	0.000508%	196,670

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: DNASE2
Protein: p.Pro71Ser
Coding: c.211C>T
MANE Select: NM_001375
dbSNP: rs150023166
Type: single nucleotide variant
Location: chr19:12881028 (GRCh38)
Gene constraint: LOEUF 1.195 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 91.52
Residue 71: a disulfide bond

Full DNASE2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

DNASE2 c.709+4A>T Uncertain significance ★★ same type
DNASE2 p.Ala332Asp Uncertain significance ★★ ⚠ same type
DNASE2 p.Arg321Trp Uncertain significance ★★ ⚠ same type
DNASE2 p.Asn69Ser Uncertain significance ★★ ⚠ same type
DNASE2 p.Cys159Trp Uncertain significance ★★ ⚠ same type
DNASE2 p.Glu43Gly Uncertain significance ★★ ⚠ same type
DNASE2 p.Gly241Ser Uncertain significance ★★ ⚠ same type
DNASE2 p.Gly286Ser Uncertain significance ★★ ⚠ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/dnase2-p-pro71ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown